ResearcherNational Cancer CenterActive in the last 2 years
Sangmyung Woo
Known by name at one institution; no external author ID yet. Name as it appears in ClinicalTrials.gov.
Their work
- Papers
- 0
- Trials
- 4 (principal investigator on 4)
- Grants
- 0
- Collaborators
- 0
2011: 1 trial · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 2 trials · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 trial
Trials 4
- Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers Principal investigator NCT06135896↗
- Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy Principal investigator NCT04241367↗
- A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy Principal investigator NCT04281511↗
- Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP) Principal investigator NCT01587534↗
Closest collaborators
No collaborators recorded.
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.